Clinical Report: Can Migraine Care Be Reliably Measured?
Overview
Expand on the specific gaps in data capture and documentation practices that hinder reliable measures.
Background
Migraine is a prevalent and debilitating condition that significantly impacts patients' quality of life. Effective management requires reliable performance measures to assess treatment quality and outcomes. The lack of suitable metrics poses challenges for healthcare providers in delivering optimal migraine care.
Data Highlights
Revise to state that no core performance measure was supported due to significant limitations.Key Findings
- The ACP identified only one existing measure related to migraine care, which they did not support due to outdated guidelines.
- Current measures lack testing at the individual physician level and show minimal room for improvement.
- Over-the-counter NSAID use is not reliably captured in electronic health records, complicating performance measurement.
- Patient-reported symptoms and nonprescription therapies are often inconsistently documented, limiting measure validity.
- Inadequate data capture and variability in documentation practices affect the reliability and feasibility of performance measurement.
Clinical Implications
Healthcare providers should be aware of the limitations in current migraine care performance measures and the challenges in documenting treatment effectiveness. Emphasizing accurate documentation and exploring innovative measurement strategies may enhance care quality.
Conclusion
The findings underscore the need for improved performance measurement in migraine care to better reflect treatment quality and patient outcomes. Addressing these gaps is essential for advancing migraine management.
References
- American College of Physicians, Annals of Internal Medicine, 2023 -- Can Migraine Care Be Reliably Measured?
- Drugs - Real World Outcomes — Factors Influencing the Limited Effectiveness of Acute Migraine Treatments in Japan: Findings from the OVERCOME (Japan) Observational Study on Migraine Epidemiology, Treatment, and Care
- Pain Medicine — Single arm feasibility trial of a mobile application for adolescent migraine management
- Brain — Activation and Sensitization of Meningeal Pain Receptors by PACAP-38: Consequences for Migraine Headaches
- American Journal of Epidemiology — Impact of Migraine and Comorbid Conditions on Severe Maternal and Neonatal Morbidity and Mortality: Findings from a Population-Based Cohort Analysis
- New ACP guideline on migraine prevention advises starting with monotherapy
- AHS & IHS Position Statements
- IHS Position statement on setting higher standards for migraine prevention published
- Re: Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis | The BMJ
- February 1, 2025 Issue of JAMA Neurology | JAMA Network
- Atogepant Outperforms Topiramate in Head-to-Head Migraine Prevention Study - MPR
- 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies - PubMed
- New ACP guideline recommends combination therapy for acute episodic migraines | EurekAlert!
- Identifying Core Clinical Topics and Recommending Core Performance Measures for Internal Medicine Physicians: A Position Paper From the American College of Physicians - PubMed
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
